Valuation: Perrigo Company plc

Market Cap 1.81B 535B 1.56B 1.47B 1.34B 2.51B 173B 2.55B 17.22B 6.73B 86.54B 6.79B 6.65B 288B P/E 2026 *
1,304x
P/E 2027 * 10.9x
Enterprise Value 4.71B 1,394B 4.08B 3.83B 3.48B 6.54B 450B 6.66B 44.86B 17.54B 225B 17.69B 17.31B 751B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.12x
Free-Float
99.6%
Yield 2026 *
8.87%
Yield 2027 * 9.1%
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.55% - - 1.81B
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.03%+0.43%+27.15%+42.67% 399.46B
Weighted average by Cap. -1.36%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 4.06B 1,200B 3.51B 3.3B 3B 5.63B 387B 5.73B 38.63B 15.1B 194B 15.24B 14.91B 647B 4.09B 1,209B 3.54B 3.33B 3.02B 5.67B 390B 5.77B 38.91B 15.21B 196B 15.35B 15.02B 652B
Net income -224M -66.26B -194M -182M -166M -311M -21.38B -316M -2.13B -834M -10.72B -841M -823M -35.72B -56.95M -16.84B -49.24M -46.32M -42.08M -79.01M -5.43B -80.4M -542M -212M -2.72B -214M -209M -9.08B
Net Debt 2.9B 859B 2.51B 2.36B 2.15B 4.03B 277B 4.1B 27.64B 10.81B 139B 10.9B 10.67B 463B 2.78B 823B 2.41B 2.26B 2.06B 3.86B 266B 3.93B 26.49B 10.36B 133B 10.45B 10.22B 444B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.04USD
Average target price
16.50USD
Spread / Average Target
+26.53%

Quarterly revenue - Rate of surprise